TD Asset Management
CCXI

TD Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

TD Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,841
Closed -$796K – 1414
2020
Q2 		$796K Buy
13,841
+4,034
+41% +$220K ﹤0.01% 1112
2020
Q1 		$394K Buy
+9,807
New +$416K ﹤0.01% 1220
2018
Q2 		– Sell
-20,300
Closed -$276K – 1455
2018
Q1 		$276K Buy
+20,300
New +$209K ﹤0.01% 1286

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

TD Asset Management's CCXI Position: Q3 2020 in Review

TD Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 13,841 shares — an estimated $796K sold.

TD Asset Management first reported a position in CCXI in Q1 2018 and held it in 3 quarters. The position peaked at $796K in Q2 2020. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • TD Asset Management reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • TD Asset Management sold 13,841 ChemoCentryx, Inc. shares in Q3 2020, an estimated $796K.
  • TD Asset Management first reported a position in ChemoCentryx, Inc. in Q1 2018 and held it in 3 quarters.
  • TD Asset Management's ChemoCentryx, Inc. position peaked at $796K in Q2 2020.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.